In developed countries, primary care physicians manage most patients with depression. Relatively few studies allow a comprehensive assessment of the decisions these doctors make in these cases and the factors associated with these decisions. We studied how general practitioners (GPs) manage the acute phase of a new episode of non-comorbid major depression (MD) and the factors associated with their decisions.
In this cross-sectional telephone survey, professional investigators interviewed an existing panel of randomly selected GPs (1249/1431, response rate: 87.3%). We used case-vignettes about new MD episodes in 8 versions differing by patient gender and socioeconomic status (blue/white collar) and disease intensity (mild/severe). GPs were randomized to receive one of these 8 versions. Overall, 82.6% chose pharmacotherapy; among them GPs chose either an antidepressant (79.8%) or an anxiolytic/hypnotic alone (18.5%). They rarely recommended referral for psychotherapy alone, regardless of severity, but 38.2% chose it in combination with pharmacotherapy. Antidepressant prescription was associated with severity of depression (OR = 1.74; 95%CI = 1.33–2.27), patient gender (female, OR = 0.75; 95%CI = 0.58–0.98), GP personal characteristics (e.g. history of antidepressant treatment: OR = 2.31; 95%CI = 1.41–3.81) and GP belief that antidepressants are overprescribed in France (OR = 0.63; 95%CI = 0.48–0.82). The combination of antidepressants and psychotherapy was associated with severity of depression (OR = 1.82; 95%CI = 1.31–2.52), patient's white-collar status (OR = 1.58; 95%CI = 1.14–2.18), and GPs' dissatisfaction with cooperation with mental health specialists (OR = 0.63; 95%CI = 0.45–0.89). These choices were not associated with either GPs' professional characteristics or psychiatrist density in the GP's practice areas.
GPs' choices for treating severe MD complied with clinical guidelines better than those for mild MD; GPs rarely recommended psychotherapy alone but rather as a complement to pharmacotherapy. Their decisions were mainly influenced by personal life experience and attitudes regarding treatment more than by professional characteristics. These results call into question the methods and content of continuing medical education in France about MD management.
Citation: Dumesnil H, Cortaredona S, Verdoux H, Sebbah R, Paraponaris A, Verger P (2012) General Practitioners' Choices and Their Determinants When Starting Treatment for Major Depression: A Cross Sectional, Randomized Case-Vignette Survey. PLoS ONE 7(12): e52429. doi:10.1371/journal.pone.0052429
Editor: James G. Scott, The University of Queensland, Australia
Received: October 16, 2012; Accepted: November 13, 2012; Published: December 18, 2012
Copyright: © 2012 Dumesnil et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The French Regional Panel of General Practices received funding from: 1) the Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques (DREES) – Ministère du travail, des relations sociales, de la famille, de la solidarité et de la ville/Ministère de la Santé et des Sports as part of the 2010–2012 contract with the Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur; 2) the Institut de la Recherche en Santé Publique (IReSP) in the frame of the Research Program 2011 “Santé mentale, prévention, prospective, thématiques générales de l'IReSP”. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
In developed countries, primary care practitioners manage most cases of depression –. Most research into this management has focused on general practitioners' (GPs) ability to recognize major depression (MD) and their pharmacological treatment of it , . Results show that they frequently underdiagnose and undertreat MD. Moreover, at the same time, numerous false positive diagnoses lead to inappropriate antidepressant prescriptions . However, relatively few studies have assessed GPs' decisions about the treatment options for managing MD or the factors associated with these decisions , , , . Yet both French and international guidelines recommend quite different strategies for MD management according to its intensity: in particular, they recommend psychotherapy as an initial treatment of mild to moderate MD and its combination with antidepressants in moderate to severe cases , –.
Studies that have analyzed the factors associated with GPs' decisions in managing MD have encountered difficulties in distinguishing the factors associated with decisions to treat individuals diagnosed with depression from those associated with the detection of these disorders . Most existing information is also limited by the inability to control for patient characteristics . Finally, studies of GP attendees may suffer from important selection biases due to the complexity of their implementation and thus the likelihood that both GPs and patients will perceive them as intrusive , . Selection biases may also arise in these studies when GPs are responsible for patient inclusion even when they are supposed to apply rigorous inclusion criteria. Case-vignette studies offer an interesting alternate as they are easily implemented and accepted, avoid the selection biases mentioned above, and can control for specific patient characteristics , .
France is among the European countries with the highest rates of psychotropic drug use and the lowest rates of referral to specialists, despite the high per capita density of psychiatrists and the high level of other mental health resources , . Continued medical education has been mandatory for French physicians since 1996. Good practice guidelines for the management of MD were issued by an independent agency in 2002 and have not been revised since. France's health care insurance funds currently have no provisions for performance payments as incentive to encourage GPs to reduce inappropriate antidepressant prescriptions.
Using a national panel of 1431 GPs in private practice that was set up in June 2010 to study GPs' attitudes and practices regarding different public health problems , we conducted a cross-sectional survey to study how GPs manage the acute phase of new cases of non-comorbid major depression (MD). The first specific aim was to describe GPs' choices among several treatment modalities: watchful waiting (assessment with scheduled follow-up but no active medication or psychotherapy treatment) ; initiating pharmacological treatment; recommending psychotherapy; providing psychological support. The second specific aim was to investigate the factors associated with these choices: we analyzed GPs' characteristics and attitudes toward different treatments for depression, MD severity  and patients' characteristics – gender and socioeconomic status (SES). We focused on these two patient characteristics, as it has been shown that GPs manage depression differently according to patient gender , ,  and SES , ; we also analyzed the density of mental health specialists in each of the GPs' practice areas, as the supply of specialists may influence GPs' choices in managing MD . The study aims were achieved.
Materials and Methods
In 2008, around 58 000 GPs (31.6% of them women) were in private practice in France . The survey described was the third of a series nested in the national panel of French GPs, designed to collect data regularly about their activity and practices. Its methodology has been presented elsewhere . Briefly, 5170 GPs were randomly selected from the Ministry of Health's exhaustive database of health professionals in France. Sampling was stratified for location of the general practice (urban, suburban, or rural), gender, age (<49, 49–56, >56), and annual workload, defined by number of office consultations and house calls (<2849, 2849–5494, >5494) in 2008. Information on each GP was obtained from the General Health Insurance Fund. To limit a selection bias that might have resulted from particular opinions/attitudes, the specific topics to be studied were not mentioned to GPs before they were asked to participate in the panel.
Of the GPs contacted and eligible, 1431 (36.8%) agreed to join, i.e., to respond to 5 consecutive surveys during a 30-month period. The GPs who refused to take part did not differ from participants according to practice location, but were more frequently male (p = 0.02), older (p<10−3), and had a higher workload in 2008 (p<10−3). Lack of time (46.2%) and lack of interest in the panel (15.6%) were the reasons given most frequently for refusal .
GPs who agreed to participate in the panel sent back a signed written consent to our team. The National Data Protection Authority (Commission Nationale Informatique et Libertés), responsible for ethical issues and protection of computerized individual data in France, approved the panel and its procedures.
Procedure and questionnaire
This cross-sectional survey took place during the last trimester of 2011. Professional investigators contacted the panel members and interviewed them with computer-assisted telephone interview (CATI) software. We developed a standardized questionnaire based on a previous qualitative study of the practices and attitudes of 32 GPs concerning the management of depression , a literature review, and discussions with experts; we pilot-tested it for clarity, length, and face validity among 50 GPs.
The questionnaire included case-vignettes — a method already been employed by several authors ,  — about patients consulting for the first time about sadness, sleep problems, and loss of appetite over the previous three weeks and diagnosed with MD. These case-vignettes were designed in several versions that varied only according to patient gender and SES (blue collar/white collar) and MD severity (mild/severe). These 2×2×2 conditions produced 8 versions (see Appendix S1), and GPs were randomized to receive one of them . Participants were first asked if they would manage these cases or refer the patient to a mental health specialist (referred to hereafter as “specialist”) for complete management (pharmacological and psychotherapeutic treatment). GPs who would continue to manage the cases were asked questions about the management they would choose: watchful waiting; provision of psychological support; prescription of pharmacological treatment and its type (antidepressant/anxiolytic/hypnotic); or referral for psychotherapy. The questionnaire also covered the GPs' professional (Table 1) and personal characteristics, their opinions about psychotherapy (efficacy, barriers to access), their cooperation with mental health specialists (utility, satisfaction), and their opinions and practices in the area of depression management (Table 2).
Finally, we obtained from the Ministry of Health data about the number of private-practice psychiatrists per 100 000 inhabitants in each GP's local area (specifically, “bassin de vie”, defined by the National Institute for Statistics and Economic Studies (INSEE) as the smallest area in which residents have access to usual daily services and work). GPs generally tend to refer their patients to psychiatrists in private practice, as public-sector psychiatrists primarily treat patients with severe mental illness.
Because of the differences mentioned above between GPs who participated in the panel and those who refused, we weighted the data to match the sample more closely to the national French GP population for age, gender, location of practice, and 2008 workload , . To take the sample stratification and weighting into account, we used Rao-Scott Chi-2 tests to examine bivariate associations.
We built a score of GPs' perceptions of the effectiveness of psychotherapy by summing the responses to 3 questions about these perceptions (alpha Cronbach = 0.70, Table 2) and a score of GPs' perceptions of the utility of cooperation with mental health specialists by summing the responses to 3 questions about these perceptions (alpha Cronbach = 0.84, Table 2).
We conducted weighted univariate and then multivariate logistic regressions of the factors associated with the following dependent variables: 1) among GPs who reported that they would start medical treatment by recommending antidepressants (versus any treatment not including antidepressants); 2) among GPs proposing antidepressants, recommending that they be combined with psychotherapy (versus without psychotherapy). All models were adjusted for GPs' gender, age, GPs' 2008 workload, and general practice location. Explanatory variables significant at p<0.15 in univariate analyses were introduced into the multivariate model and kept according to a backward selection procedure (exit criterion: p≥0.05). Model fit was assessed with the Hosmer-Lemeshow goodness-of-fit test. Analyses were performed with SAS version 9.2 (SAS Institute, Cary, NC).
Of the 1431 GPs initially included in the panel, 1249 (87.3%) agreed to participate in this survey; those who refused did not differ significantly from participants according to gender, age, place of practice or number of office visits and house calls in 2008 (Table 1). Table 2 reports GPs' personal characteristics and opinions about treatment for major depression. Most GPs felt they were adequately trained to treat major depression and that they did so effectively. A majority of GPs had a favorable perception of the effectiveness of psychotherapy but only 35% found that cooperation with mental health specialists was satisfactory (Table 2).
The great majority of GPs would manage cases of MD themselves, without referring the patient directly to a mental health specialist, although some would seek advice from a specialist. Figure 1 presents the GPs' initial choices for all of the case-vignettes. Note that these choices varied according to severity: 84.7% of GPs assigned a mild case-vignette would choose to start active treatment immediately without a specialist's advice, while 13.9% said that they would opt for watchful waiting; in the severe cases the corresponding figures were 87.2% and 9.3% (p<0.01). Sixty percent of GPs would provide psychological support in mild cases and 68.4% in severe ones (p<0.01; total percentage: 64.0%). The percentages of GPs who chose exclusive pharmacotherapy, pharmacotherapy combined with psychotherapy, and psychotherapy alone are presented in Figure 2. These too differed significantly according to severity (p<0.01). Differences according to severity were also found among the participants who chose pharmacotherapy regarding the kinds of psychotropic drugs proposed (p<0.001, Figure 2): 74.9% who were randomized to case-vignettes of mild MD would choose an antidepressant and 85.1% of those responding to a severe case (p<0.001). Among GPs who reported that they would manage the cases (whatever their treatment choice) the total percentage of GPs choosing antidepressants was 66.2%. Among GPs who reported that they would suggest antidepressant treatment, 41.4% also said they would propose psychotherapy in mild cases and 54.0% in severe cases (p<0.001; total percentage: 47.9%).
a Calculated among GPs managing the patient themselves without any specialist's advice and GPs who would take advice on the diagnosis before managing the patient b Calculated among GPs recommending a drug treatment.
In the first multivariate logistic regression (Table 3), the choice of antidepressants was negatively associated with the doctor being a woman, having had psychotherapy, and believing that antidepressants are over-prescribed in France, and with the patient being a woman. It was also positively associated with severity, the GP's personal or family history of depression, and the GP's personal history of antidepressant treatment. GPs who generally often/very often treated mild to moderate MD with pharmacotherapy alone also chose antidepressant treatment more often than the other GPs. Neither the professional characteristics of GPs nor the local density of private psychiatrists were associated with this first dependent variable.
In the second multivariate logistic regression (Table 4), a combination of antidepressants and psychotherapy was negatively associated with GPs' age, their opinion that they are adequately trained to manage depression, and a low level of satisfaction about cooperation with mental health specialists. Choosing this combination was positively associated with the doctor being a woman, an intermediate or high score for favorable perception of the effectiveness of psychotherapy in treating depression, a high score for perception of the utility of cooperation with mental health specialists, severity of depression, and high patient SES. The GPs' professional characteristics, their opinions on barriers to access to psychotherapy, and private psychiatrists density were not associated with this second dependent variable.
This study is to our knowledge the first national study to use a randomized case-vignette methodology to conduct a global assessment of how primary care physicians manage patients with newly diagnosed non-comorbid MD. Among GPs responding to these case-vignettes, nearly two-thirds would provide psychological support, and the great majority would propose pharmacotherapy, with or without psychotherapy. Among the latter, 79.8% would choose an antidepressant (with or without anxiolytic/hypnotic) and 18.5% an anxiolytic/hypnotic alone. Respondents rarely chose psychotherapy alone, regardless of case severity. Antidepressant prescription was associated with severity, patient gender, and GP personal characteristics. The combination of antidepressant treatment and psychotherapy was associated with severity of depression, patient SES, and GPs' opinions, especially about the quality of cooperation with mental health specialists in treating depression.
Active treatment versus watchful waiting
As observed in previous case-vignette studies , , GPs were much more likely to suggest immediate (85.9%) active treatment than watchful waiting (11.7%). Moreover the percentage for the latter, substantially lower than in earlier studies (20%–41%), suggests that French GPs are mostly inclined to start active treatment for MD immediately, regardless of its severity. Reasons may include their sense of effectiveness in managing this disease and their dissatisfaction about access to and cooperation by mental health specialists (Table 2). This conduct is in line with French guidelines and those in other countries (e.g. the CANMAT guidelines in Canada), given that an MD diagnosis per se implies the need for immediate treatment , . However, the NICE clinical guidelines (UK) allow “active monitoring” for patients who, in the practitioner's judgment, may recover without any formal intervention, or have mild depression and do not want intervention, or have sub-threshold depressive symptoms and request an intervention . Some authors suggest that watchful waiting might reflect the GP's uncertainty about the diagnosis and treatment utility . In the French context, where most GPs have confidence in their ability to manage MD, this choice might also reflect disagreement with the guidelines.
Psychological support by GPs
A relatively high percentage of GPs in our study would provide psychological support to patients with MD. This is in line with previous publications showing that family physicians attach much importance to giving such support to depressed patients , . It is also something patients expect . The omission of any mention of this in French guidelines for depression management  suggests, however, that GPs have constructed their own vision of how to manage MD.
The percentage of French GPs choosing pharmacotherapy first (with or without psychotherapy, 82.6%) was in the upper range of the figures published in other studies of family physicians (34%–94%) reviewed by Kosteniuk et al. . Among GPs recommending pharmacotherapy, a non-negligible percentage (18.5%) recommended anxiolytic/hypnotic drugs alone (Table 2). GPs are likely to prescribe anxiolytics or hypnotics to patients with major depression , , ,  even though these drugs are not recommended alone to treat this disease, even when its intensity is mild , , . Guidelines in France  recommend prescribing these drugs when starting an antidepressant treatment for the shortest possible period only in case of marked symptoms of anxiety, agitation or insomnia, symptoms not present in our case-vignettes.
Antidepressant treatment and associated factors
Although antidepressants remained the treatment chosen most frequently by our study's participants (66.2%), this percentage is moderate compared with other studies, where it sometimes exceeded 80% , –. Our results suggest that some GPs hesitate to prescribe antidepressants even in severe MD. Indeed, GPs do not unanimously believe that antidepressants universally produce satisfactory results , . They may also anticipate that patients will be reluctant to use antidepressants and plan several consultations to overcome this reluctance . Finally, some GPs may have internalized the French public authorities' messages about the over-prescription of psychotropic drugs (Table 2), as suggested by the slight decrease in antidepressants prescribed in France in 2006–2009 (minus 1% per year) . These messages must nonetheless be carefully tailored to avoid dissuading GPs from prescribing antidepressants when these drugs are indicated.
GPs' personal life experiences of depression, psychotherapy, and antidepressant treatment influenced their choice to use antidepressants when professional characteristics in particular CME did not (Table 3). Swedish studies ,  found that GPs consider their personal qualities and life experiences more influential in treating depression than academic education and professional literature. This may lead them to make non-optimal choices in managing MD. GPs' education on this topic should incorporate the results of studies such as these to increase awareness of the possible gap between their practices and recommendations and evidence-based medicine that may occur when relying more on life experience rather than on scientific evidence.
Our finding that GPs would prescribe antidepressants less often to women than men is consistent with some publications , but contradicts others, which either found no association ,  or an inverse one , . Gender differences in diagnosis and treatment of depression found in population studies  have been ascribed to women seeking medical care more often than men, verbalizing their symptoms more effectively, and requesting medication more often . There are several possible reasons for the higher level of antidepressant prescriptions in our male vignettes, however: depressive symptoms of similar intensity may be perceived by GPs as more severe in men, and GPs may take into account the higher risk of suicide in men than in women .
Psychotherapy and associated factors
The percentage of GPs who would recommend pharmacotherapy alone and in combination with psychotherapy was similar, as previously observed in case-vignettes  and population studies . In all, about 40% of GPs recommended referral for psychotherapy, which is strikingly close to the rate of psychotherapy among patients with mood disorders (47%) in the ESEMeD population study . Nonetheless, GPs were reluctant to propose psychotherapy alone as a first-line treatment (3.5%) even in mild MD, when it is especially recommended by, among others, French, British, and US guidelines , , . In other studies reviewed by Kosteniuk et al. , 7% to 47% of family physicians would recommend psychotherapy to treat MD. Despite relatively favorable perceptions of the effectiveness of psychotherapy in treating MD (2/3 of the GPs in our study had an intermediate-to-high score for this perception, Table 3), the majority recommended psychotherapy only as a complement to antidepressants, as reported elsewhere .
GPs chose the combination of antidepressant drugs and psychotherapy more frequently in the severe than the mild cases (Table 4). This is consistent with French and international guidelines , , although the latter also recommend this combination in mild to moderately severe MD when specific conditions are present (e.g., psychosocial, interpersonal problems, or an axis II disorder). Low patient SES appeared to be a barrier to this combination (Table 4). A previous study in France found that psychotherapy is underutilized by depressed patients with a low educational level . Psychotherapy in France is, at best, only partially reimbursed, and frequently not at all; this policy choice might partially explain our results, as might the attitude of many GPs, who considered psychotherapy better suited to highly educated patients than to others (Table 2).
GPs' perceptions of the utility of cooperation with mental health specialists and their satisfaction with it, their perceptions of both the effectiveness of psychotherapy and the adequacy of their own training were the main attitudinal factors associated with their decision to combine antidepressants and psychotherapy (Table 4). On the other hand, neither their opinions about the barriers related to the provision of and/or access to psychotherapy nor the density of private psychiatrists in their practice areas were associated with this recommendation. A previous population-based study in France did, however, find this density to be associated with lifetime recourse to psychotherapy . Environmental constraints regarding access to psychotherapy might have a substantially greater impact on patient uptake than on their GPs' recommendations.
Limits and strengths of the study
The participation rate in this survey was high, reflecting good adherence to the panel. Moreover, GPs who did not participate in this survey did not differ from participants for gender, age, place of practice, or 2008 workload. The survey was cross-sectional: therefore, the observed links should be interpreted with caution. Nonetheless, the quasi-experimental design we followed in applying the case-vignette strengthens our findings especially as to patient gender and SES and disease intensity, because it allowed us to control these characteristics . Moreover, the vignette method reduced bias by presenting patients who were standardized  and allowed us to include almost all panel participants . Although the design and wording of the case-vignette was as close as possible to a real situation, this method cannot ensure that responses reflect the way GPs would behave in a real situation : it cannot take into account the doctor-patient interactions that shape clinician behavior . However it had acceptable face validity with different degrees of MD severity leading to different management , and its results were consistent with those of a population study .
In this case-vignette study of new cases of MD, GPs made decisions that complied better with clinical guidelines for severe cases than for mild ones. Although most GPs were favorable to psychotherapy, their choices indicate that they did not use it as stand-alone treatment for depression. At the same time, some of them appeared careful in recommending antidepressants when starting MD treatment, which suggests that they have internalized the messages of French public health authorities about over-prescription of antidepressants in France. Finally, GPs' decisions about the treatment choices were influenced mainly by their personal characteristics and life experience, their attitudes toward treatments and patients' gender and SES, but not by continuing medical education or barriers to access to psychotherapy and/or specialists. These results raise questions about the methods, models, and content of continuing medical education used in France for the management of MD. Developing new educational programs to increase GPs' knowledge of the different treatment strategies for MD and their indications and improving cooperation between them and mental health specialists are necessary steps for improving access to adequate treatment for primary care patients.
We thank all GPs who participated in the survey as well as the members of the supervisory committee of the French National Panel of Ambulatory General Practices (DRESS; ORS and URPS-ML of Burgundy, Pays de la Loire, and Provence-Alpes-Côte d'Azur). We also thank Jo Ann Cahn for her help with editing and Anne M. Lovell (INSERM-CERMES 3) for her invaluable advice.
Conceived and designed the experiments: PV HD AP RS HV. Performed the experiments: HD. Analyzed the data: SC. Contributed reagents/materials/analysis tools: PV HD AP RS HV. Wrote the paper: HD.
- 1. Kovess-Masfety V, Alonso J, Brugha TS, Angermeyer MC, Haro JM, et al. (2007) Differences in lifetime use of services for mental health problems in six European countries. Psychiatr Serv 58: 213–220.
- 2. National Collaborating Centre for Mental Health (2009) Depression: The treatment and management of depression in adults (partial update of the NICE clinical guideline 23). NICE clinical guideline 90. London (UK): National Institute for Health and Clinical Excellence. 64p.
- 3. Timonen M, Liukkonen T (2008) Management of depression in adults. Bmj 336: 435–439.
- 4. Vasiliadis HM, Lesage A, Adair C, Boyer R (2005) Service use for mental health reasons: cross-provincial differences in rates, determinants, and equity of access. Can J Psychiatry 50: 614–619.
- 5. Kendrick T, King F, Albertella L, Smith PW (2005) GP treatment decisions for patients with depression: an observational study. Br J Gen Pract 55: 280–286.
- 6. Kosteniuk J, Morgan D, D'Arcy C (2012) Treatment and follow-up of anxiety and depression in clinical-scenario patients: survey of Saskatchewan family physicians. Can Fam Physician 58: e152–158.
- 7. Mitchell AJ, Vaze A, Rao S (2009) Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 374: 609–619.
- 8. Hyde J, Calnan M, Prior L, Lewis G, Kessler D, et al. (2005) A qualitative study exploring how GPs decide to prescribe antidepressants. Br J Gen Pract 55: 755–762.
- 9. Mercier A, Auger-Aubin I, Lebeau JP, Van Royen P, Peremans L (2011) Understanding the prescription of antidepressants: a Qualitative study among French GPs. BMC Fam Pract 12: 99.
- 10. [National Agency for Health Accreditation and Evaluation] Agence Nationale d'Accréditation et d'Evaluation en Santé (2002) [Outpatient management of isolated depressive episodes in adults] Prise en charge d'un épisode dépressif isolé de l'adulte en ambulatoire. [Clinical guidelines] Recommandations pour la pratique clinique [in French]. Paris: ANAES. 85 p.
- 11. Bauer M (2007) Updated WFSBP Guidelines for the Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry 8: 66.
- 12. Kilbourne AM, Daugherty B, Pincus HA (2007) What do general medical guidelines say about depression care? Depression treatment recommendations in general medical practice guidelines. Curr Opin Psychiatry 20: 626–631.
- 13. Epstein SA, Hooper LM, Weinfurt KP, DePuy V, Cooper LA, et al. (2008) Primary care physicians' evaluation and treatment of depression: Results of an experimental study using video vignettes. Med Care Res Rev 65: 674–695.
- 14. Verger P, Saliba B, Rouillon F, Kovess-Masfety V, Villani P, et al. (2008) Determinants of coprescription of anxiolytics with antidepressants in general practice. Can J Psychiatry 53: 94–103.
- 15. Ross S, Moffat K, McConnachie A, Gordon J, Wilson P (1999) Sex and attitude: a randomized vignette study of the management of depression by general practitioners. Br J Gen Pract 49: 17–21.
- 16. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, et al. (2004) Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl: 47–54.
- 17. Verger P, Flicoteaux R, Schwarzinger M, Sagaon-Teyssier L, Peretti-Watel P, et al. (2012) Pandemic Influenza (A/H1N1) Vaccine Uptake among French Private General Practitioners: A Cross Sectional Study in 2010. PLoS One 7: e41837.
- 18. Meredith LS, Cheng WJ, Hickey SC, Dwight-Johnson M (2007) Factors associated with primary care clinicians' choice of a watchful waiting approach to managing depression. Psychiatr Serv 58: 72–78.
- 19. Kisely S, Linden M, Bellantuono C, Simon G, Jones J (2000) Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study. Psychol Med 30: 1217–1225.
- 20. Bernheim SM, Ross JS, Krumholz HM, Bradley EH (2008) Influence of patients' socioeconomic status on clinical management decisions: a qualitative study. Ann Fam Med 6: 53–59.
- 21. Kravitz RL, Franks P, Feldman M, Meredith LS, Hinton L, et al. (2006) What drives referral from primary care physicians to mental health specialists? A randomized trial using actors portraying depressive symptoms. J Gen Intern Med 21: 584–589.
- 22. Sicart D (2008) [Physicians: Estimates as of 1 January 2008] Les médecins: estimations au 1er janvier 2008. [Statistical Series] Série Statistique. [Office of Research, Evaluation, and Statistics] Direction de la recherche, des études, de l'évaluation et des statistiques [in French]. Paris: [Ministry of Health, Young People, and Sports] Ministère de la santé, de la jeunesse et des sports: 111 p.
- 23. Dumesnil H, Manzi J-M, Apostolidis A, Verger P (2011) [Private practitioners' strategies for the management of anxiety and depression: a qualitative survey in Marseille] Stratégies de prise en charge des troubles anxieux et dépressifs en médecine de ville : une enquête qualitative à Marseille [in French]. Marseilles: Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur. 40 p.
- 24. Potthoff RF (1994) Telephone sampling in epidemiologic research: to reap the benefits, avoid the pitfalls. Am J Epidemiol 139: 967–978.
- 25. Patten SB, Bilsker D, Goldner E (2008) The evolving understanding of major depression epidemiology: implications for practice and policy. Can J Psychiatry 53: 689–695.
- 26. Backenstrass M, Joest K, Rosemann T, Szecsenyi J (2007) The care of patients with subthreshold depression in primary care: is it all that bad? A qualitative study on the views of general practitioners and patients. BMC Health Serv Res 7: 190.
- 27. Barley EA, Murray J, Walters P, Tylee A (2011) Managing depression in primary care: A meta-synthesis of qualitative and quantitative research from the UK to identify barriers and facilitators. BMC Fam Pract 12: 47.
- 28. Johnston O, Kumar S, Kendall K, Peveler R, Gabbay J, et al. (2004) Qualitative study of depression management in primary care: GP and patient goals, and the value of listening. Br J Gen Pract 57: 872–879.
- 29. Ogden J, Bavalia K, Bull M, Frankum S, Goldie C, et al. (2004) “I want more time with my doctor”: a quantitative study of time and the consultation. Fam Pract 21: 479–483.
- 30. Bartels SJ, Horn S, Sharkey P, Levine K (1997) Treatment of depression in older primary care patients in health maintenance organizations. Int J Psychiatry Med 27: 215–231.
- 31. Kirby M, Denihan A, Bruce I, Radic A, Coakley D, et al. (1999) Benzodiazepine use among the elderly in the community. Int J Geriatr Psychiatry 14: 280–284.
- 32. American Psychiatric Association (2010) Practice guideline for the treatment of patients with major depressive disorder, third edition. Arlington (VA): American Psychiatric Association. 152 p.
- 33. Kennedy SH, Lam RW, Morris B (2003) Clinical guidelines for depressive disorders. Summary of recommendations relevant to family physicians. Can Fam Physician 49: 489–491.
- 34. Martin-Agueda B, Lopez-Munoz F, Rubio G, Guerra JA, Silva A, et al. (2005) Management of depression in primary care: a survey of general practitioners in Spain. Gen Hosp Psychiatry 27: 305–312.
- 35. Stafford RS, MacDonald EA, Finkelstein SN (2001) National Patterns of Medication Treatment for Depression, 1987 to 2001. Prim Care Companion J Clin Psychiatry 3: 232–235.
- 36. Tarricone R, Fattore G, Gerzeli S, Serra G, Taddei C, et al. (2000) The costs of pharmacological treatment for major depression. The Italian Prospective Multicentre Observational Incidence-Based Study. Pharmacoeconomics 17: 167–174.
- 37. Andersson SJ, Troein M, Lindberg G (2001) Conceptions of depressive disorder and its treatment among 17 Swedish GPs. A qualitative interview study. Fam Pract 18: 64–70.
- 38. [National Health Insurance Fund] Caisse Nationale d'Assurance Maladie (2011) [Medication Use and Expenditures in France and Europe. Trends 2006–2009] Consommation et dépenses de médicaments en France et en Europe. Evolutions 2006–2009 [in French]. http://www.ameli.fr/fileadmin/user_upload/documents/DP_Consommation_medicaments_en_Europe_vdef_01.pdf. Accessed 2 October 2012.
- 39. Andersson SJ, Troein M, Lindberg G (2005) General practitioners' conceptions about treatment of depression and factors that may influence their practice in this area. A postal survey. BMC Fam Pract 6: 21.
- 40. Frayne SM, Skinner KM, Lin H, Ash AS, Freund KM (2004) Effect of patient gender on late-life depression management. J Womens Health (Larchmt) 13: 919–925.
- 41. Williams JB, Spitzer RL, Linzer M, Kroenke K, Hahn SR, et al. (1995) Gender differences in depression in primary care. Am J Obstet Gynecol 173: 654–659.
- 42. Wright AF (1988) Psychological distress: outcome and consultation rates in one general practice. J R Coll Gen Pract 38: 542–545.
- 43. Briffault X, Sapinho D, Villamaux M, Kovess V (2008) Factors associated with use of psychotherapy. Soc Psychiatry Psychiatr Epidemiol 43: 165–171.
- 44. Verger P, Arnaud S, Ferrer S, Iarmarcovai G, Saliba ML, et al. (2008) Inequities in reporting asbestos-related lung cancer: influence of smoking stigma and physician's specialty, workload and role perception. Occup Environ Med 65: 392–397.
- 45. Peabody JW, Luck J, Glassman P, Jain S, Hansen J, et al. (2004) Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med 141: 771–780.